Strategic partners Potential sales opportunity with CROs and eClinical technology providers connected to Veeva’s partner ecosystem, highlighted by recent collaborations and program expansions such as the IDDI partnership and Copli acquisition. Leverage these networks to cross-sell Ostro as the AI engagement layer for life sciences.

AI platform expansion Position Ostro as a complement to Veeva’s growing AI product lines and Vault AI innovations, targeting customers investing in AI-enabled engagement, patient/provider interaction orchestration, and compliant, multi-channel outreach across therapeutic areas.

Regulatory readiness Emphasize Ostro’s compliant AI capabilities as a value add for pharma brands navigating regulatory environments, with potential upsell to sponsors prioritizing compliant, omnichannel engagement as part of digital transformation in clinical, regulatory, safety and quality domains.

Mid-market focus Target mid-size and emerging manufacturers in life sciences that fit the 51-200 employee and $50M-$100M revenue bracket, offering Ostro as a scalable engagement platform to accelerate provider and patient interactions without large enterprise commitments.

Global outreach Leverage Veeva’s international footprint and recent European market activities to identify opportunities in multilingual, multi-region campaigns where Ostro’s AI-powered engagement can optimize cross-border communications and regional compliance.